Atara Planning Phase 3 Trials of ATA188 in Non-active SPMS, PPMS & Seizing the Day With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Atara may open two Phase 3 clinical trials of ATA188, an immunotherapy targeting EBV-infected B-cells in non-active progressive MS patients.

He also reads “Upon Reflection, I’m Determined to Seize the Day” from "The MS Wire," a column by Ed Tobias.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/